Project description
Exosome isolation using sound
Acoustic separation of cells employs ultrasound to separate cells with different physical properties such as size or density from each other. Funded by the European Innovation Council, the AcouSome project proposes to utilise ultrasound for the separation of exosomes. Exosomes are membrane-enclosed extracellular vesicles that carry proteins, lipids and nucleic acids, and they function as a means of communication between cells and tissues. Given the emerging role of exosomes in various diseases, the overarching goal of AcouSome is to generate an approach for quick and easy isolation of exosomes for both research and diagnostic purposes.
Objective
AcouSome is a consortium stemming from the ongoing EIC-FET Open BioWings project, and consists of four of the BioWings project
partners (AcouSort AB, DTU, Lund University and Day One Srl). AcouSome has the ambition to build on the disruptive technology of
thin film actuated acoustofluidics developed in BioWings. The results obtained in BioWings will be combined with a polymer
acoustofluidics technology developed in the ongoing Eurostars AcouPlast project to fabricate a polymer-based microfluidic chip for
separating and enriching exosomes from blood for use in the next generation of point-of-care diagnostics.
Exosomes are nano-sized extracellular vesicles that are released by a significant number of different cell types. They are considered an
important biomarker, with high diagnostic potential in a wide range of diseases, including different kinds of cancer (glioblastoma,
melanoma, prostate cancer and many others), hepatitis, kidney, cardiovascular and liver diseases. Therefore, there is an increasing
interest in exosomes as a powerful diagnostic tool. Having the opportunity to isolate and analyze exosomes from a routine blood test
is crucial for early detection of a wide range of diseases.
In the AcouSome chip exosomes will be separated and enriched from blood by combining two steps already developed by Lund
University and AcouSort. First plasma will be separated from blood by flowing the blood through a microfluidic channel, pushing the
cells towards the centerline of the channel using ultrasoundand and subsequently splitting the cell and plasma flows. Exosomes will
then be trapped and enriched from the plasma flow using a localized acoustic field. The acoustofluidic chip will be driven using
thin-film actuators as invented together with DTU in the BioWings project. The exosome separation cartridge is intended for sample
preparation in research labs and future diagnostic point-of-care instruments.
Fields of science
- natural sciencesphysical sciencesclassical mechanicsfluid mechanicsmicrofluidics
- engineering and technologyother engineering and technologiesmicrotechnologylab on a chip
- engineering and technologymedical engineeringmedical laboratory technologydiagnostic technologies
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectrical engineeringpiezoelectrics
- natural sciencesphysical sciencesacousticsultrasound
Keywords
Programme(s)
- HORIZON.3.1 - The European Innovation Council (EIC) Main Programme
Funding Scheme
HORIZON-EIC - HORIZON EIC GrantsCoordinator
223 81 Lund
Sweden
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.